Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin-containing treatment-shortening regimens for pulmonary tuberculosis
PACTR201110000124315Recruiting
- Sponsor
- UCL Centre for Medical Microbiology
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Open-label trial of moxifloxacin in pulmonary tuberculosis (TB), sponsored by UCL Centre for Medical Microbiology. Started Jan 2008; status: recruiting.
02
Drugs
moxifloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201110000124315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201110000124315.